Target intelligence / Profile preview

Leiomodin-2 (LMOD2)

Target
LMOD2
Molecular classification
Actin-binding protein, Thin filament assembly protein, Muscle structural protein, Other
01

Overview

Leiomodin-2 (LMOD2) is a muscle-specific, actin-binding protein primarily expressed in cardiac muscle, where it is essential for the elongation and regulation of thin filaments within sarcomeres. LMOD2 mediates actin nucleation and polymerization, specifically binding at the pointed ends of actin filaments to promote elongation without capping—a role crucial for achieving mature filament length. Its absence or dysfunction leads to abnormal thin filament morphology, defective sarcomere assembly, and severe reduction of contractile force, culminating in dilated cardiomyopathy or other myopathies. LMOD2 is not currently a therapeutic target, nor are there approved drugs or biomarkers targeting it, but it is mechanistically central to muscle contractility and a cause of inherited muscle diseases when mutated.

Other names
Cardiac leiomodinC-LMODC-LmodCLMODCMD2GLeiomodin, cardiac leiomodinleiomodin-2leiomodin 2 (cardiac)
02

Biological functions

Regulation of actin filament lengthPromotion of actin nucleation and polymerizationThin filament elongation in striated muscle (cardiac and skeletal muscle)Essential for sarcomere organizationRegulation of contractile force and cardiac/skeletal muscle function
03

Disease associations

Cardiomyopathy (especially dilated cardiomyopathy)Heart failureNemaline myopathy (linked to mutations)Skeletal muscle weakness/myopathy
04

Safety considerations

Reduced or absent LMOD2 function is associated with severe contractile and functional defects in heart and skeletal muscle, leading to conditions such as heart failure and nemaline myopathy

Beyond the preview

Go deeper on Leiomodin-2 (LMOD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leiomodin-2 (LMOD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call